Biodexa Pharmaceuticals Plc (BDRX) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BDRX Revenue Growth
BDRX Revenue Analysis (2014–2025)
As of May 8, 2026, Biodexa Pharmaceuticals Plc (BDRX) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, BDRX's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $1.9 million in 2018.
When compared to Healthcare sector peers including SIGA (-22.1% YoY), NUVB (+1205.5% YoY), and ACAD (+9.9% YoY). Compare BDRX vs SIGA →
BDRX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BDRXCurrent | $0 | - | - | - | |
 SIGA | $95M | -22.1% | -5.4% | 25.1% | |
 NUVB | $63M | +1205.5% | - | -338.7% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% |
BDRX Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-184,857 | - | $-8,268,734 | - |
| 2024 | $0 | -100.0% | $-5,437,000 | - | $-9,199,000 | - |
| 2023 | $381K | -45.5% | $-3,686,000 | -967.5% | $-8,014,000 | -2103.4% |
| 2022 | $699K | +20.9% | $-4,412,000 | -631.2% | $-8,932,000 | -1277.8% |
| 2021 | $578K | +68.5% | $-4,076,000 | -705.2% | $-6,998,000 | -1210.7% |
| 2020 | $343K | -49.1% | $-5,725,000 | -1669.1% | $-23,040,000 | -6717.2% |
| 2019 | $674K | -65.2% | $-7,169,000 | -1063.6% | $-11,318,000 | -1679.2% |
| 2018 | $1.9M | +96.0% | $-7,421,000 | -382.9% | $-11,815,000 | -609.6% |
| 2017 | $989K | -25.2% | $-7,340,000 | -742.2% | $-11,776,000 | -1190.7% |
| 2016 | $1.3M | -3.8% | $-6,407,000 | -484.3% | $-9,652,000 | -729.6% |
See BDRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BDRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BDRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBDRX — Frequently Asked Questions
Quick answers to the most common questions about buying BDRX stock.
Is BDRX's revenue growth accelerating or slowing?
BDRX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is BDRX's long-term revenue growth rate?
Biodexa Pharmaceuticals Plc's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is BDRX's revenue distributed by segment?
BDRX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.